Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Leafs4Lifeon Nov 28, 2018 3:07pm
182 Views
Post# 29035356

RE:RE:Shareholders

RE:RE:Shareholders LDS generated 900k in September,  1.17m in revenue last month, and people expect them to do something like 1.5m in November. Will they hit that number? We will find when they relese their form 7 on December 7th. 

Shareholders think strips and reveur should be available in numerous dispensaries in the first week of December. Why do we think that? Because Brad said as much in an interview two weeks ago. Will Brad keep his word? Who knows, if history is a guide he will probably blow the deadline and feed some new excuse. 

Some of us longs are not Kool Aid drinkers. LDS does not have to be revolutionary in order to be a good investment because the price is so low. 

At 40 cents LDS's market cap is under 50 million. If they generate 1.5 million in November (without strips or reveur) then they will be priced around 2x sales. Most US cannabis companies are priced between 7 and 12x 2019 sales. 

Everyone might be doing concentrates and oils (as you claim) but not everyone with access to the California market is publicly traded and priced this cheaply.

I'm not saying make it a core position or go long for 5 years or anything. But I am saying if LDS delivers on 1.5 million for November revenue they are really underpriced at these levels. So if you think they can deliver you should buy some here and then sell it when the price moves up. If you think LDS sales will disappoint, then sell your shares or buy something else. 

Baker3434 wrote: Could you tell  me what LDS has to offer that every other MJ company doesnt already offer, and has had product in stores since legalization. They have LDS has all but blown the Cannastrip deal. The delivery system is nothing any different than any other company claims there strips can do. Everyone is doing concentrates and oil, so what do they offer thats different? 


Bullboard Posts